ARQT
Arcutis Biotherapeutics Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $24.84
- Day High
- $25.11
- Day Low
- $24.6
- Day Open
- $24.59
- Volume
- 38548
- Day Change
- -0.16%
Latest news data for ARQT
Arcutis Completes Enrollment in INTEGUMENT-1 Pivotal Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis
globenewswire.com
The Goldman Sachs Group Increases Arcutis Biotherapeutics (NASDAQ:ARQT) Price Target to $50.00
etfdailynews.com
Morgan Stanley Increases Arcutis Biotherapeutics (NASDAQ:ARQT) Price Target to $45.00
etfdailynews.com
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Up 13% Following Analyst Upgrade
etfdailynews.com
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Arcutis Biotherapeutics Announces Pricing of Public Offering of Common Stock
globenewswire.com
Arcutis Biotherapeutics, Inc. : Opinion positive de Goldman Sachs
zonebourse.com
Arcutis Biotherapeutics, Inc. : Morgan Stanley toujours positif
zonebourse.com
Arcutis to Host Investor Conference Call Today to Discuss the FDA Approval of ZORYVE™ (roflumilast) Cream 0.3% for Plaque Psoriasis
globenewswire.com
FDA Approves Arcutis' ZORYVE Cream For Treatment Of Plaque Psoriasis In Patients 12 Years And Older
markets.businessinsider.com